This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Cancer or Spine Metastasis
and you are
between 18 and 90
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

One of the complications of having cancer in the spinal vertebrae is that it can spread and lead to compression of the spinal cord. Spinal cord compression is a serious event that needs to be treated quickly in order to prevent permanent damage to the spinal cord and nerves. - Researchers currently do not have the ability to accurately predict whether cancer of the vertebrae will cause spinal cord compression. It is possible that accurate predictions could allow doctors to treat patients even before they develop symptoms of spinal cord compression, thereby preventing some of the long-term consequences. Objectives: - To compare patients with cancer of the spinal vertebrae with and without symptoms of spinal cord compression by looking at markers in the blood and changes on novel magnetic resonance imaging (MRI) techniques that might allow researchers to predict who will experience spinal cord compression before they actually begin to have symptoms. Eligibility: - One group of healthy volunteers 18 years of age and older. - One group of patients 18 years of age and older who have cancer that has spread to the vertebrae without symptoms of spinal cord compression. - One group of patients 18 years of age and older who have cancer that has spread to the vertebrae with symptoms of spinal cord compression. Design: - Healthy volunteers: - Blood will be drawn from each volunteer for initial tests and for more specific biomarker tests. - Comprehensive MRI of the spine, followed by a special type of MRI called diffusion tensor imaging (DTI). It is believed that DTI may be even more sensitive in revealing spinal cord abnormalities than regular MRI sequences. - Patients with cancer of the vertebrae: - Researchers will obtain information such as pathology reports, laboratory results, diagnosis and treatment history, physical exam (PE) information, results of scans such as x-rays, MRI, computerized tomography (CT), and positron emission tomography (PET), and planned treatment details. - Additional blood samples will be taken for specific biomarker tests. - Questionnaire about pain, unusual sensations or numbness, bladder or bowel problems, and mobility. - Comprehensive MRI of the spine, followed by a DTI. - Patients who appear to have symptoms of spinal cord compression will be offered standard radiation treatment.
Tris trial is registered with FDA with number: NCT00928382. The sponsor of the trial is National Cancer Institute (NCI) and it is looking for 30 volunteers for the current phase.
Official trial title:
A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression